Multicenter Study Tracks Long-Term Rituximab Outcomes in Anti-MAG Neuropathy
In a multicenter retrospective study of 149 French patients with anti-MAG neuropathy, 36 percent experienced long-term functional improvement following rituximab ...
In a multicenter retrospective study of 149 French patients with anti-MAG neuropathy, 36 percent experienced long-term functional improvement following rituximab ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.